Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Kenyan court charges 8 schoolgirls with fellow students' murder
At least 5 people killed in fire in Antwerp apartment block
Three people die in Mexico World Cup celebrations as fans crowd streets
US and Iran enter technical talks to secure peace deal, shipping restart
After Venezuela quakes, citizens lead rescues amid military theft accusations
Two dead after wildfire guts house in northern Greece
Afghanistan launches airstrikes on IS targets on border with Pakistan
Bangladesh warns of dengue surge as weather aids spread
